Miramar Capital LLC Acquires Shares of 405 UnitedHealth Group Incorporated (NYSE:UNH)

Miramar Capital LLC acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) in the fourth quarter, Holdings Channel reports. The fund acquired 405 shares of the healthcare conglomerate’s stock, valued at approximately $203,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Assetmark Inc. increased its holdings in shares of UnitedHealth Group by 5.2% in the 3rd quarter. Assetmark Inc. now owns 213,353 shares of the healthcare conglomerate’s stock valued at $83,366,000 after purchasing an additional 10,463 shares during the period. Lincoln National Corp increased its holdings in shares of UnitedHealth Group by 15.1% in the 4th quarter. Lincoln National Corp now owns 8,951 shares of the healthcare conglomerate’s stock valued at $4,495,000 after purchasing an additional 1,174 shares during the period. Dohj LLC increased its holdings in shares of UnitedHealth Group by 4.2% in the 3rd quarter. Dohj LLC now owns 6,446 shares of the healthcare conglomerate’s stock valued at $2,968,000 after purchasing an additional 257 shares during the period. YorkBridge Wealth Partners LLC increased its holdings in shares of UnitedHealth Group by 1.8% in the 4th quarter. YorkBridge Wealth Partners LLC now owns 15,296 shares of the healthcare conglomerate’s stock valued at $7,681,000 after purchasing an additional 272 shares during the period. Finally, Rafferty Asset Management LLC increased its holdings in shares of UnitedHealth Group by 52.5% in the 3rd quarter. Rafferty Asset Management LLC now owns 30,064 shares of the healthcare conglomerate’s stock valued at $11,747,000 after purchasing an additional 10,349 shares during the period. Institutional investors own 86.07% of the company’s stock.

In other news, Director Richard T. Burke sold 6,000 shares of the firm’s stock in a transaction on Friday, February 25th. The stock was sold at an average price of $470.38, for a total value of $2,822,280.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Paul R. Garcia bought 2,146 shares of the stock in a transaction dated Tuesday, February 22nd. The stock was acquired at an average price of $464.97 per share, with a total value of $997,825.62. The disclosure for this purchase can be found here. Over the last three months, insiders have sold 18,000 shares of company stock valued at $8,776,840. Company insiders own 0.55% of the company’s stock.

A number of research firms recently commented on UNH. Truist Financial increased their price objective on UnitedHealth Group from $575.00 to $610.00 in a report on Thursday, April 7th. Cowen increased their price objective on UnitedHealth Group from $512.00 to $596.00 in a report on Monday, April 18th. Credit Suisse Group increased their price objective on UnitedHealth Group from $564.00 to $595.00 and gave the stock an “outperform” rating in a report on Monday, April 18th. Wells Fargo & Company increased their price objective on UnitedHealth Group from $565.00 to $613.00 and gave the stock an “overweight” rating in a report on Friday, April 22nd. Finally, Oppenheimer increased their price objective on UnitedHealth Group from $550.00 to $600.00 and gave the stock an “outperform” rating in a report on Monday, April 18th. Two equities research analysts have rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group has an average rating of “Buy” and a consensus target price of $550.17.

UNH stock traded up $10.61 during midday trading on Thursday, hitting $524.42. The stock had a trading volume of 2,578,571 shares, compared to its average volume of 3,354,360. The firm has a market capitalization of $492.40 billion, a price-to-earnings ratio of 28.70, a P/E/G ratio of 1.67 and a beta of 0.88. UnitedHealth Group Incorporated has a 52 week low of $383.12 and a 52 week high of $553.29. The stock has a 50-day simple moving average of $505.88 and a 200 day simple moving average of $478.76. The company has a current ratio of 0.78, a quick ratio of 0.79 and a debt-to-equity ratio of 0.54.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 EPS for the quarter, topping the consensus estimate of $5.38 by $0.11. The firm had revenue of $80.15 billion during the quarter, compared to analysts’ expectations of $78.77 billion. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. UnitedHealth Group’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same period last year, the business earned $5.31 earnings per share. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 21.75 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 22nd. Investors of record on Monday, March 14th were given a $1.45 dividend. The ex-dividend date was Friday, March 11th. This represents a $5.80 annualized dividend and a yield of 1.11%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 31.75%.

UnitedHealth Group Profile (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.